Shariah screening · sector
Halal Healthcare Stocks
688 Healthcare issuers carry a screening verdict, out of 1,750 issuers we hold in this sector. Verdicts come from two independent engines and each row says which.
Verdict split
451 compliant 26%
237 non-compliant 14%1 questionable 0%
1,061 no verdict yet 61%
449 screened by our own engine against published ratio methodologies computed from primary filings · 335 carrying a reviewed third-party provider verdict.
Screened issuers
Compliant first, then alphabetical. Every row links to that issuer's full ratio breakdown, business-activity screen and the filing behind it.
| Issuer | Verdict | Screened | Source |
|---|---|---|---|
| MYO | NO VERDICT | — | not screened yet |
| MYGN Myriad Genetics, Inc. | NON-COMPLIANT | 2026-11-05 | provider |
| 9887.HK Nanjing Leads Biolabs Co., Ltd. | NON-COMPLIANT | 2026-08-28 | in-house |
| 600682.SS Nanjing Xinjiekou Department Store Co., Ltd. | NON-COMPLIANT | 2026-08-26 | in-house |
| NASC | NO VERDICT | — | not screened yet |
| NATCOPHARM.NS NATCO Pharma Limited | NON-COMPLIANT | 2026-08-26 | in-house |
| NAUT | NO VERDICT | — | not screened yet |
| NBRVF | NO VERDICT | — | not screened yet |
| NCEL | NO VERDICT | — | not screened yet |
| NCNA | NO VERDICT | — | not screened yet |
| NECLIFE.NS Nectar Lifesciences Limited | UNRATED | 2026-08-28 | in-house |
| NEOG Neogen Corp. | NON-COMPLIANT | 2026-11-05 | provider |
| NEPTF Neptune Wellness Solutions Inc. | UNRATED | 2026-08-28 | in-house |
| NERV | NO VERDICT | — | not screened yet |
| NEUP | NO VERDICT | — | not screened yet |
| NEU.AX Neuren Pharmaceuticals Limited | NON-COMPLIANT | 2026-08-28 | in-house |
| NRSN NeuroSense Therapeutics Ltd. | UNRATED | 2026-08-28 | in-house |
| NAMS NewAmsterdam Pharma Company N.V. | UNRATED | 2026-08-28 | in-house |
| NGEN | NO VERDICT | — | not screened yet |
| NGHLF | NO VERDICT | — | not screened yet |
| NGNE | NO VERDICT | — | not screened yet |
| NIKA | NO VERDICT | — | not screened yet |
| NIKI | NO VERDICT | — | not screened yet |
| NKTR | NO VERDICT | — | not screened yet |
| NKTX | NO VERDICT | — | not screened yet |
| NMRA | NO VERDICT | — | not screened yet |
| NNVC | NO VERDICT | — | not screened yet |
| 600812.SS North China Pharmaceutical Company.Ltd | NON-COMPLIANT | 2026-08-26 | in-house |
| NBP NovaBridge Biosciences | NON-COMPLIANT | 2026-08-28 | in-house |
| NVCR NovoCure Ltd | NON-COMPLIANT | 2026-11-02 | provider |
| NPHC | NO VERDICT | — | not screened yet |
| NRIX | NO VERDICT | — | not screened yet |
| NSPR | NO VERDICT | — | not screened yet |
| NSTM | NO VERDICT | — | not screened yet |
| NTHI | NO VERDICT | — | not screened yet |
| NTLA | NO VERDICT | — | not screened yet |
| NTRB | NO VERDICT | — | not screened yet |
| NTRR | NO VERDICT | — | not screened yet |
| NUMD | NO VERDICT | — | not screened yet |
| NUNZ | NO VERDICT | — | not screened yet |
| NUVB | NO VERDICT | — | not screened yet |
| NUWE | NO VERDICT | — | not screened yet |
| NVAX | NO VERDICT | — | not screened yet |
| NVCT | NO VERDICT | — | not screened yet |
| NVNO | NO VERDICT | — | not screened yet |
| 4565.T Nxera Pharma Co., Ltd. | NON-COMPLIANT | 2026-08-26 | in-house |
| NXGL | NO VERDICT | — | not screened yet |
| NXL | NO VERDICT | — | not screened yet |
| NXTC | NO VERDICT | — | not screened yet |
| NYKD.OL Nykode Therapeutics AS | UNRATED | 2026-08-28 | in-house |
| NYMXF | NO VERDICT | — | not screened yet |
| NYXH Nyxoah SA | NON-COMPLIANT | 2026-10-08 | provider |
| NYXH.BR Nyxoah SA | UNRATED | 2026-08-28 | in-house |
| OABI | NO VERDICT | — | not screened yet |
| OBIO | NO VERDICT | — | not screened yet |
| OBX | NO VERDICT | — | not screened yet |
| OCEA | NO VERDICT | — | not screened yet |
| OCGN | NO VERDICT | — | not screened yet |
| OCUL | NO VERDICT | — | not screened yet |
| OCS Oculis Holding AG | UNRATED | 2026-08-28 | in-house |
| ODTX | NO VERDICT | — | not screened yet |
| ODYY | NO VERDICT | — | not screened yet |
| OFIX | NO VERDICT | — | not screened yet |
| OGEN | NO VERDICT | — | not screened yet |
| OGI | NO VERDICT | — | not screened yet |
| OHCFF | NO VERDICT | — | not screened yet |
| OJSY | NO VERDICT | — | not screened yet |
| OKUR | NO VERDICT | — | not screened yet |
| OKYO OKYO Pharma Limited | UNRATED | 2026-08-28 | in-house |
| OLMA | NO VERDICT | — | not screened yet |
| OLYMY | NO VERDICT | — | not screened yet |
| OM | NO VERDICT | — | not screened yet |
| OMER | NO VERDICT | — | not screened yet |
| ONCO.ST Oncopeptides AB (publ) | NON-COMPLIANT | 2026-09-08 | in-house |
| ONCY | NO VERDICT | — | not screened yet |
| ONSS | NO VERDICT | — | not screened yet |
| ONWD.BR Onward Medical N.V. | NON-COMPLIANT | 2026-08-28 | in-house |
| ONWRF | NO VERDICT | — | not screened yet |
| OPHLF | NO VERDICT | — | not screened yet |
| OPHLY | NO VERDICT | — | not screened yet |
| OPK Opko Health Inc | NON-COMPLIANT | 2026-10-08 | provider |
| IRD Opus Genetics, Inc. Common Stock | NON-COMPLIANT | 2026-10-08 | provider |
| ORMP Oramed Pharmaceuticals Inc. | UNRATED | 2026-08-28 | in-house |
| ORX.ST Orexo AB (publ) | NON-COMPLIANT | 2026-08-27 | in-house |
| OGI.TO Organigram Global Inc. | UNRATED | 2026-08-28 | in-house |
| ORGS | NO VERDICT | — | not screened yet |
| ORIOLA.HE Oriola Oyj | NON-COMPLIANT | 2026-08-27 | in-house |
| ORKA | NO VERDICT | — | not screened yet |
| ORY.MC Oryzon Genomics S.A. | UNRATED | 2026-08-28 | in-house |
| OSE.PA OSE Immunotherapeutics SA | NON-COMPLIANT | 2026-08-27 | in-house |
| OSRH | NO VERDICT | — | not screened yet |
| OSTX | NO VERDICT | — | not screened yet |
| OSUR | NO VERDICT | — | not screened yet |
| OTLC | NO VERDICT | — | not screened yet |
| OTLK | NO VERDICT | — | not screened yet |
| OBCK.F Ottobock SE & Co. KGaA | NON-COMPLIANT | 2026-08-28 | in-house |
| OVID | NO VERDICT | — | not screened yet |
| OWPC | NO VERDICT | — | not screened yet |
| OXB.L Oxford Biomedica plc | NON-COMPLIANT | 2026-08-27 | in-house |
| ONT.L Oxford Nanopore Technologies plc | NON-COMPLIANT | 2026-08-27 | in-house |
Showing 1,301–1,400 of 1,750
Industries in Healthcare
11 industries under this sector, ordered by how many of their issuers carry a decided verdict.
Biotechnology
59 compliant of 149 decided, 606 not screened yet.
Drug Manufacturers - Specialty & Generic
97 compliant of 134 decided, 139 not screened yet.
Medical Devices
34 compliant of 55 decided, 110 not screened yet.
Diagnostics & Research
27 compliant of 38 decided, 20 not screened yet.
Medical Care Facilities
25 compliant of 37 decided, 37 not screened yet.
Medical Instruments & Supplies
16 compliant of 24 decided, 37 not screened yet.
Health Information Services
14 compliant of 19 decided, 58 not screened yet.
Drug Manufacturers - General
15 compliant of 18 decided, 11 not screened yet.
Pharmaceutical Retailers
4 compliant of 14 decided, 17 not screened yet.
Medical Distribution
4 compliant of 12 decided, 13 not screened yet.
Healthcare Plans
2 compliant of 3 decided, 4 not screened yet.